Fundamentals of molecular imaging? [PR IV.A.3.b).(2).(e)]
Biological and pharmacologic actions of materials administered in diagnostic or therapeutic procedures? [PR IV.A.3.b).(2).(f)]
Will each resident participate in at least 3 low dose therapies involving oral administration of I-131 and at least 3 high dose therapies involving oral administration of I-131? [PR IV.A.5.a).(2).(a)]
Will this include participation in patient selection, informed consent, understanding and calculating the administered dose, counseling of patients and their families on radiation safety issues and patient follow up? [PR IV.A.5.a).(2).(a).(i)]